Report #2888244

Received Mar 9, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: TX
Recovered: Unknown
Vaccinated: Feb 24, 2026
Onset: Feb 24, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RVX	ROTAVIRUS (NO BRAND NAME)	UNKNOWN MANUFACTURER	UNK	2096661	OT

Symptoms (1)

Product storage error

Symptom narrative

Medical assistant reported ROTATEQ was administered after a temperature excursion; This spontaneous report was received from a physician assistant (reported as medical assistant) (C.M.A) and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, previous drugs reactions and allergies were not reported. On 24-Feb-2026, the patient was vaccinated with improperly stored (48.1 F for 28 hours, no previous temperature excursion) rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral solution, administered orally as prophylaxis (Lot No. 2096661 has been verified to be a valid lot number for [rotavirus vaccine, live, oral, pentavalent], expiration date reported and upon internal validation established as 07-Mar-2026) (exact dose was not reported) (product storage error). No further information was provided. This is one of 6 reports received from the same reporter.